Dhananjay B. Patankar
Plus aucun poste en cours
Profil
Dhananjay B.
Patankar worked as the Head of Biopharmaceutical Development at Syngene International Ltd.
and as the Chief Operations & Technology Officer at Intas Biopharmaceuticals Ltd.
He holds a doctorate degree from the University of Utah and a graduate degree from the Indian Institute of Technology Bombay.
Anciens postes connus de Dhananjay B. Patankar
| Sociétés | Poste | Fin |
|---|---|---|
| SYNGENE INTERNATIONAL LIMITED | Corporate Officer/Principal | 01/06/2022 |
Intas Biopharmaceuticals Ltd.
 Intas Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Intas Biopharmaceuticals Ltd. researches and develops pharmaceutical products. It manufactures Pegylated GCSF in India and markets under the brand name NEUPEG. The company was founded in 2000 and is headquartered in Ahmedabad, India. | Directeur des opérations | - |
Formation de Dhananjay B. Patankar
| University of Utah | Doctorate Degree |
| Indian Institute of Technology Bombay | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SYNGENE INTERNATIONAL LIMITED | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Intas Biopharmaceuticals Ltd.
Intas Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Intas Biopharmaceuticals Ltd. researches and develops pharmaceutical products. It manufactures Pegylated GCSF in India and markets under the brand name NEUPEG. The company was founded in 2000 and is headquartered in Ahmedabad, India. | Health Technology |